Difficulty: Medium
Average Score: 83%
Practice
The client is being given Pradaxa (dabigatran). The nurse knows that the mechanism of action of this drug is what?
Correct answer
B
Rationale
Step-by-step rationale for choice B:
1. Pradaxa is a direct thrombin inhibitor.
2. Thrombin is a key enzyme in the blood clotting process.
3. By directly inhibiting thrombin, Pradaxa prevents the formation of blood clots.
4. This mechanism differs from antiplatelet drugs (A), fibrinolytic medications (C), and clotting factor production interference (D).
Summary:
- Choice A is incorrect as Pradaxa does not affect platelets directly.
- Choice C is incorrect as Pradaxa does not promote the breakdown of clots like fibrinolytics.
- Choice D is incorrect as Pradaxa does not interfere with the production of clotting factors.
1. Pradaxa is a direct thrombin inhibitor.
2. Thrombin is a key enzyme in the blood clotting process.
3. By directly inhibiting thrombin, Pradaxa prevents the formation of blood clots.
4. This mechanism differs from antiplatelet drugs (A), fibrinolytic medications (C), and clotting factor production interference (D).
Summary:
- Choice A is incorrect as Pradaxa does not affect platelets directly.
- Choice C is incorrect as Pradaxa does not promote the breakdown of clots like fibrinolytics.
- Choice D is incorrect as Pradaxa does not interfere with the production of clotting factors.